Skip to main content

Proove Opioid Response

Proove Biosciences has launched Proove Opioid Response, a clinical laboratory test to predict a patient's response to opioid pain medications. The test provides physicians information about which opioids a patient is likely to respond to and assesses 49 genetic variations for information about safety and effectiveness in five specific opioids — hydrocodone, oxycodone, morphine, tramadol, and hydromorphone.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.